|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Marketable securities | |||||||||||||||||||
| Prepaid expenses | |||||||||||||||||||
| Trade and other receivables | |||||||||||||||||||
| Inventory, net | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Restricted cash | |||||||||||||||||||
| Marketable securities | |||||||||||||||||||
| Property and equipment, net | |||||||||||||||||||
| Acquired in-process research and development | |||||||||||||||||||
| Right of use asset | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Accounts payable | |||||||||||||||||||
| Accrued expenses | |||||||||||||||||||
| Current portion of long-term debt | |||||||||||||||||||
| Current portion of deferred rent | |||||||||||||||||||
| Current portion of deferred revenue | |||||||||||||||||||
| Current portion of lease liability | |||||||||||||||||||
| Current other liabilities | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Long-term debt | |||||||||||||||||||
| Long-term deferred rent | |||||||||||||||||||
| Deferred tax liability | |||||||||||||||||||
| Long-term deferred revenue | |||||||||||||||||||
| Long-term lease liability | |||||||||||||||||||
| Other liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Stockholders’ equity: | |||||||||||||||||||
| Preferred stock, $0.001 par value. Authorized, 5,000,000 shares; no shares issued or outstanding | |||||||||||||||||||
| Total preferred stock, $0.001 par value. Authorized, 5,000,000 shares; no shares issued or outstanding | |||||||||||||||||||
| Common stock, $0.001 par value. Authorized, 150,000,000 shares; 37,764,213 shares issued and 37,686,301 shares outstanding as of December 31, 2018; 38,940,860 shares issued and 38,519,183 shares outstanding as of September 30, 2019 | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Treasury stock, at cost, 77,912 shares as of December 31, 2018 and 421,677 shares as of September 30, 2019 | |||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||||||
Loading...
